> top > docs > PMC:7696151 > spans > 1765-2156 > annotations

PMC:7696151 / 1765-2156 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
52 51-58 Chemical denotes quinine MESH:D011803
53 107-135 Disease denotes systemic lupus erythematosus MESH:D008180
58 169-176 Chemical denotes quinine MESH:D011803
61 185-192 Disease denotes malaria MESH:D008288

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T3 107-135 Phenotype denotes systemic lupus erythematosus http://purl.obolibrary.org/obo/HP_0002725

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T17 47-144 Sentence denotes The quinine soon began to be also used for the treatment of systemic lupus erythematosus [1,2,3].
T18 145-276 Sentence denotes The increasing need for quinine, due to malaria diffusion, led the pharmaceutical industry to the creation of a synthetic molecule.
T19 277-340 Sentence denotes In 1934 Johann (Hans) Andersag and co-workers at the Bayer I.G.